Researchers Say New Drug Could Reduce Sepsis Deaths: “The drug, a genetically engineered version of a natural
substance from human cells called activated protein C, will
be marketed under the brand name Zovant if it is approved.
Experts predicted that Zovant would be very expensive, but
a spokesman for Lilly declined to discuss the price.

The drug is not an antibiotic, and does not treat the
underlying infections that lead to sepsis. Instead, it quells
inflammation and abnormalities in blood clotting, which
contribute to the high death rates of 30 percent to 50
percent among patients who contract sepsis.” New York Times